Low-quality drugs in India raise concerns | Chemical & Engineering News
Volume 94 Issue 9 | p. 19 | Concentrates
Issue Date: February 29, 2016

Low-quality drugs in India raise concerns

By K. V. Venkatasubramanian, Special to C&EN
Department: Government & Policy
Keywords: pharmaceuticals, Asia, consumer safety, India, drug quality

Indian researchers have found that significant percentages of diclofenac sodium, a painkiller, and amoxicillin trihydrate, an antibiotic, sold in the country are of low quality. The published findings by a team led by Ahmed Nawaz Khan, assistant professor of pharmacy at Jaypee University of Information Technology, showed a higher percentage than the government’s national estimates for drugs that are substandard, meaning the products do not meet quality benchmarks (J. Appl. Pharm. . . .

To view the rest of this content, please log in with your ACS ID.



 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society